Search for: [Abstract = "treatment of hand eczema, none contained active substances with effectiveness in HE treatment confirmed in high\- or moderate quality clinical trials. The present analysis has also demonstrated that for some of the diseases from the spectrum of eczema, neither expert guidelines, nor drugs licensed for the given indication were available.Conclusions\: There are considerable discrepancies between expert recommendations for pharmacotherapy of diseases from the spectrum of eczema, the scientific evidence for the effectiveness of recommended drugs, and the acceptable use of the drugs as determined by the Summaries of Product Characteristics \(SPC\) that are in force in Poland. The SPC do not reflect the current state of medical knowledge. Therefore, for the sake of patients, it is necessary to elaborate protocols of treatment routines acceptable to all stakeholders in the health system which would be based on scientific evidence for effectiveness and safety of the drugs, as well as their cost\-effectiveness."]
